A detailed history of Applied Finance Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 2,017 shares of BIIB stock, worth $322,377. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,017
Previous 3,362 40.01%
Holding current value
$322,377
Previous $779 Million 16.36%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$189.07 - $236.8 $254,299 - $318,496
-1,345 Reduced 40.01%
2,017 $907 Million
Q2 2024

Jul 31, 2024

BUY
$190.52 - $236.72 $640,528 - $795,852
3,362 New
3,362 $779 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Applied Finance Capital Management, LLC Portfolio

Follow Applied Finance Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Applied Finance Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Applied Finance Capital Management, LLC with notifications on news.